Study Stopped
Lack of institutional support and IRB related issues.
Study of Psycho-Social Impact of Keloid
1 other identifier
observational
1,000
1 country
1
Brief Summary
Despite their benign nature, keloids may constitute a severe aesthetic, and in some cases, functional problem which translates to various repercussions on person's quality of life, including much stress and insecurities. Keloids are mostly observed between the ages of 10 and 30. Although keloid is a common condition and the investigators can make assumptions about those living with keloids, the investigators do not know the actual impact of the illness on the overall performance of patients' and how this disease, day to day, is impacting their lives. The investigators are conducting this study, aimed to investigate the psychosocial impact of keloid on daily life. Information is collected anonymously. You must be 18 years of age or older to take this survey. Parents can respond on behalf of their children who are not 18 years of age yet. The online survey will take 20-30 minutes to complete.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2012
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 20, 2011
CompletedFirst Posted
Study publicly available on registry
November 23, 2011
CompletedStudy Start
First participant enrolled
September 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2012
CompletedOctober 18, 2016
October 1, 2016
Same day
November 20, 2011
October 17, 2016
Conditions
Keywords
Eligibility Criteria
All patients with clinical diagnosis of Keloid are invited to particiapate in this study.
You may qualify if:
- Clinical Diagnosis of Keloid
- Informed consent
- Age above 18 to answer the survey questions
- Parents shall respond on behalf of their minor children
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Michael H. Tirgan MD
New York, New York, 10024, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michael H Tirgan, MD
Keloid Research Foundation
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- INDIV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 20, 2011
First Posted
November 23, 2011
Study Start
September 1, 2012
Primary Completion
September 1, 2012
Study Completion
September 1, 2012
Last Updated
October 18, 2016
Record last verified: 2016-10